Russia's Sputnik V vaccine 91.6 percent effective against symptomatic COVID-19 in interim analysis

Russia's coronavirus vaccine
(Image credit: Getty Images)

Russia's Sputnik V vaccine has been found in an interim analysis to be 91.6 percent effective against symptomatic COVID-19.

The interim phase 3 trial analysis for Russia's vaccine was confirmed in a peer review from the medical journal The Lancet, which showed that it provided full protection against moderate and severe COVID-19 cases, the Financial Times reports.

This COVID-19 vaccine, which requires two doses, was already approved by authorities in Russia in August 2020, even though it hadn't yet undergone large clinical trials, The Wall Street Journal notes. In The Lancet, virology professors Ian Jones and Polly Roy addressed the criticism of this quick process that lacked "transparency."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

"The development of the Sputnik V vaccine has been criticized for unseemly haste, corner cutting, and an absence of transparency," they wrote. "But the outcome reported here is clear and the scientific principle of vaccination is demonstrated, which means another vaccine can now join the fight to reduce the incidence of COVID-19."

The Financial Times notes this would mean there are now three COVID-19 vaccines globally with a confirmed efficacy rate of more than 90 percent, after Pfizer's and Moderna's. According to CNN, the Sputnik vaccine has already been administered to over 2 million people globally.

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Brendan Morrow

Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.